Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. (2021)

First Author: Morschhauser F
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-020-01108-x

PubMed Identifier: 33328591

Publication URI: http://europepmc.org/abstract/MED/33328591

Type: Journal Article/Review

Volume: 35

Parent Publication: Leukemia

Issue: 7

ISSN: 0887-6924